Zynerba Pharmaceuticals: Analysts See More Upside after the Rally

Mark O'Hara - finance.yahoo.com Posted 5 years ago
image
Zynerba Pharmaceuticals: Analysts See More Upside after the Rally
More

Zynerba Pharmaceuticals: Analysts See More Upside after the RallyZynerba PharmaceuticalsSo far, Zynerba Pharmaceuticals (ZYNE) has seen an upwards price action of 265% in 2019. Analysts see more upside in the stock. The mean consensus target price

Story continues